Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.
Discover
Back to filter
Show all topics (10)
Related topics
How to Improve Your Viral Nucleic Acid Extraction Processes
Sep 6, 2021
High-Throughput Extraction with CyBio FeliX
Have you missed Cytek Aurora Cell Sorter launch @CYTO 2021?
Aug 17, 2021
If you have missed our Cytek Aurora Cell Sorter introduction at CYTO2021, here is another...
Comparison of gamma and x-ray irradiation results
Aug 12, 2021
Biological effects of Cs-137 and X-ray irradiators are comparable with regards to...
Recorded Webinar – the basics of Intravital Fluorescence Microscopy
Aug 6, 2021
This is the first of a 4-part series introducing Scintica’s newly formed relationship...
Hypoxia further exacerbates myopathy in broilers via alteration of satellite cell fate
Aug 2, 2021
Woody breast (WB) condition has created a variety of challenges for the global poultry...
High quality Bioluminescence and X-Ray analysis in lung squamous cell carcinoma
Jul 21, 2021
Spectral Instruments Imaging provides unrivaled sensitivity for bioluminescence,...
Pretargeted delivery of PI3K/mTOR small-molecule inhibitor–loaded nanoparticles
Jul 3, 2021
Overactivation of the PI3K/mTOR signaling has been identified in non-Hodgkin’s lymphoma....
Quantitative two-photon microscopy imaging analysis of human skin
Jul 1, 2021
Transdermal skin delivery is a method to transport various topical formulations to a deeper skin layer non-invasively....
Elevated NSD3 histone methylation activity drives squamous cell lung cancer
Jun 8, 2021
This work identifies NSD3 as a principal 8p11-12 amplicon-associated oncogenic driver in...
Cytek Aurora webinar: design of immuno-oncology panels for research and clinical routine
May 11, 2021
During this webinar we will...
Functional Imaging
Aug 9, 2018
We bring you the latest KOL interview on the Albira Si PET/SPECT/CT from CHUV Lausanne. Prof. Prior is the head of Nuclear Medicine of the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne as well as Vice-President of the Swiss Society of Nuclear Medicine. In this short interview he describes benefits of combination of the PET, SPECT and CT modalities of Albira Si for their research.
Brand profile
